Literature DB >> 11016826

Endogenous ouabain and its binding globulin: effects of physical exercise and study on the globulin's tissue distribution.

R Antolovic1, N Bauer, M Mohadjerani, H Kost, H Neu, U Kirch, E G Grünbaum, W Schoner.   

Abstract

Ouabain, that has been isolated from bovine adrenals and hypothalamus, is a new cardiotonic steroid hormone, which is either synthesized in the adrenals or stored there after it has absorbed from the diet. Little is known in vivo which events may lead to the release of ouabain into blood. Moreover, a binding protein for cardiotonic steroids exists in blood, which binds cardiac glycosides with high affinity. It may affect the action of endogenous ouabain on heart and circulation, but the physiological function of this protein is unclear. To realize, which physiological stimuli in vivo may affect blood concentrations of endogenous ouabain and which function the cardiotonic binding protein may have in modulating ouabain effects, the effect of physical exercise on endogenous ouabain was studied and the tissue distribution of its binding protein was investigated. We found that endogenous ouabain changes rapidly in blood upon physical exercise and behaves like expected for a hormone of circulation. The cardiotonic steroid binding globulin shows the highest concentration in the kidney, which suggests that sodium pumps of the kidney are protected against its inhibition by ouabain which would lead not only to natriuresis but also to a deleterious loss of glucose, amino acids and phosphate.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11016826     DOI: 10.1291/hypres.23.supplement_s93

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  9 in total

Review 1.  Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

Authors:  Alexei Y Bagrov; Joseph I Shapiro; Olga V Fedorova
Journal:  Pharmacol Rev       Date:  2009-03       Impact factor: 25.468

Review 2.  Novel role of ouabain as a cystogenic factor in autosomal dominant polycystic kidney disease.

Authors:  Gustavo Blanco; Darren P Wallace
Journal:  Am J Physiol Renal Physiol       Date:  2013-06-12

3.  Functional Interaction Between Na/K-ATPase and NMDA Receptor in Cerebellar Neurons.

Authors:  Evgeny E Akkuratov; Olga M Lopacheva; Markus Kruusmägi; Alexandr V Lopachev; Zahoor A Shah; Alexander A Boldyrev; Lijun Liu
Journal:  Mol Neurobiol       Date:  2014-11-08       Impact factor: 5.590

4.  Ouabain stimulates a Na+/K+-ATPase-mediated SFK-activated signalling pathway that regulates tight junction function in the mouse blastocyst.

Authors:  Holly Giannatselis; Michele Calder; Andrew J Watson
Journal:  PLoS One       Date:  2011-08-25       Impact factor: 3.240

5.  Ouabain affects the expression of activation markers, cytokine production, and endocytosis of human monocytes.

Authors:  Mariana Pires Teixeira; Vivian Mary Rumjanek
Journal:  Mediators Inflamm       Date:  2014-05-08       Impact factor: 4.711

Review 6.  Much More than a Cardiotonic Steroid: Modulation of Inflammation by Ouabain.

Authors:  Luiz H A Cavalcante-Silva; Éssia de Almeida Lima; Deyse C M Carvalho; José M de Sales-Neto; Anne K de Abreu Alves; José G F M Galvão; Juliane S de França da Silva; Sandra Rodrigues-Mascarenhas
Journal:  Front Physiol       Date:  2017-11-10       Impact factor: 4.566

Review 7.  Role of endogenous ouabain in the etiology of bipolar disorder.

Authors:  Rif S El-Mallakh; Yonglin Gao; Pan You
Journal:  Int J Bipolar Disord       Date:  2021-02-01

Review 8.  Endogenous Cardiac Steroids in Bipolar Disorder: State of the Art.

Authors:  Rif S El-Mallakh; Vishnu Priya Sampath; Noa Horesh; David Lichtstein
Journal:  Int J Mol Sci       Date:  2022-02-06       Impact factor: 5.923

Review 9.  Defence mitigation by predators of chemically defended prey integrated over the predation sequence and across biological levels with a focus on cardiotonic steroids.

Authors:  Shabnam Mohammadi; Lu Yang; Matthew Bulbert; Hannah M Rowland
Journal:  R Soc Open Sci       Date:  2022-09-07       Impact factor: 3.653

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.